| Candice Renee Faria, NURSE PRACTITIONER | |
|
4320 Diplomacy Dr, Suite 2300, Anchorage, AK 99508-5925 | |
| (907) 729-3300 | |
| Not Available |
| Full Name | Candice Renee Faria |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 4320 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184094930 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 104818 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlas Medical Alaska Llc | 0345630463 | 10 |
News Archive
Eph receptors and their partner proteins, the ephrins, are vital for intercellular communication.
With the advent of healthcare reform, the United States is embarking on an unprecedented effort to determine which health care intervention works best for the diagnosis or treatment of a given disease or condition. While comparative effectiveness and personalized medicine evolved separately, these significant trends interface, increasingly, in the healthcare systems.
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) - an innovative oral chemotherapy - for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.
Modulating immune response to injury could accelerate the regeneration of severed peripheral nerves, a new study in an animal model has found. By altering activity of the macrophage cells that respond to injuries, researchers dramatically increased the rate at which nerve processes regrew.
Phenomix Corporation today announced positive top-line results from a six-month Phase 3 study comparing dutogliptin 400mg and 200mg once daily as monotherapy versus placebo for the treatment of patients with Type 2 diabetes mellitus. Dutogliptin is Phenomix' internally-discovered dipeptidyl peptidase-4 (DPP-4) inhibitor.
› Verified 8 days ago
| Entity Name | Atlas Medical Alaska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376213207 PECOS PAC ID: 0345630463 Enrollment ID: O20211205000014 |
News Archive
Eph receptors and their partner proteins, the ephrins, are vital for intercellular communication.
With the advent of healthcare reform, the United States is embarking on an unprecedented effort to determine which health care intervention works best for the diagnosis or treatment of a given disease or condition. While comparative effectiveness and personalized medicine evolved separately, these significant trends interface, increasingly, in the healthcare systems.
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) - an innovative oral chemotherapy - for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.
Modulating immune response to injury could accelerate the regeneration of severed peripheral nerves, a new study in an animal model has found. By altering activity of the macrophage cells that respond to injuries, researchers dramatically increased the rate at which nerve processes regrew.
Phenomix Corporation today announced positive top-line results from a six-month Phase 3 study comparing dutogliptin 400mg and 200mg once daily as monotherapy versus placebo for the treatment of patients with Type 2 diabetes mellitus. Dutogliptin is Phenomix' internally-discovered dipeptidyl peptidase-4 (DPP-4) inhibitor.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Candice Renee Faria, NURSE PRACTITIONER 4320 Diplomacy Dr, Suite 2300, Anchorage, AK 99508-5925 Ph: (907) 729-3300 | Candice Renee Faria, NURSE PRACTITIONER 4320 Diplomacy Dr, Suite 2300, Anchorage, AK 99508-5925 Ph: (907) 729-3300 |
News Archive
Eph receptors and their partner proteins, the ephrins, are vital for intercellular communication.
With the advent of healthcare reform, the United States is embarking on an unprecedented effort to determine which health care intervention works best for the diagnosis or treatment of a given disease or condition. While comparative effectiveness and personalized medicine evolved separately, these significant trends interface, increasingly, in the healthcare systems.
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) - an innovative oral chemotherapy - for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.
Modulating immune response to injury could accelerate the regeneration of severed peripheral nerves, a new study in an animal model has found. By altering activity of the macrophage cells that respond to injuries, researchers dramatically increased the rate at which nerve processes regrew.
Phenomix Corporation today announced positive top-line results from a six-month Phase 3 study comparing dutogliptin 400mg and 200mg once daily as monotherapy versus placebo for the treatment of patients with Type 2 diabetes mellitus. Dutogliptin is Phenomix' internally-discovered dipeptidyl peptidase-4 (DPP-4) inhibitor.
› Verified 8 days ago
Ms. Mary Kay Mccarty, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3925 Tudor Centre Dr, #100, Anchorage, AK 99508 Phone: 907-561-8301 Fax: 907-561-8170 | |
Mindy Lorin Schloss, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6852 Cutty Sark St, Anchorage, AK 99502 Phone: 907-243-5936 | |
Katherine L Sterner, A.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4201 Tudor Centre Dr, Suite 320, Anchorage, AK 99508 Phone: 907-729-4955 | |
Sandra Frenier, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr, Suite 452, Anchorage, AK 99508 Phone: 907-562-2120 | |
Janet A Bloch, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper St, U340, Anchorage, AK 99508 Phone: 907-562-0321 Fax: 907-562-2683 | |
Lois A Rockcastle, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3801 University Lake Dr Ste 205, Anchorage, AK 99508 Phone: 907-563-1600 Fax: 907-563-0100 | |
Mrs. Megan Renee Hathcoat, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1200 Airport Heights Dr Ste 200, Anchorage, AK 99508 Phone: 907-262-4278 |